Zimmer Biomet  

Welcome to Zimmer Biomet! Your Progress. Our Promise.

Zimmer Biomet Spine is a leader in restoring mobility, alleviating pain, and improving the quality of life for patients around the world by delivering surgeons a comprehensive portfolio of quality spine technologies and procedural innovation, best-in-class training, and unparalleled service via a network of responsive team members and sales professionals.

Brands: MyMobility, ROSA ONE, WalterLorenz, Mobi-C, The Tether, TrellOss, Vital Deformity, Vital Degenerative, Vital Power, Primagen, VirageOCT, Timberline, MaxAn, ProLift


Mobi-C Biomechanics
The Tether
See What's Possible with mymobility
Zimmer Biomet mymobility Introduction

 Press Releases

  • WARSAW, Ind., October 7, 2020 – Zimmer Biomet will be showcasing its latest commercial offerings and previewing its next generation of technological innovations at the North American Spine Society (NASS) Annual Meeting: Virtual Experience, October 6 through 9.

    “In addition to our ongoing commitment to advancing our implant offerings, Zimmer Biomet is transforming the Spine patient journey with the introduction of a digital care management platform called mymobility® with Apple Watch at this year’s NASS meeting,” said Jim Cloar, President, Spine.

    “In our discussions with spine surgeons about mymobility with Apple Watch, they are excited about the data collection capabilities and the ability to connect and engage with patients through an automated platform,” said Liane Teplitsky, Vice President and General Manager of Technology and Data Solutions. “Overall, we’ve found that patients prefer a more connected experience and surgeons are looking for an efficient way to provide it to them.”

    mymobility with Apple Watch

    mymobility with Apple Watch is a digital care management system that uses iPhone and Apple Watch to help clinicians deliver support and guidance to their patients through a connected experience. mymobility with Apple Watch delivers continuous data and patient-reported feedback to facilitate care, outcomes and satisfaction for patients’ surgical preparation and recovery.

    Mobi-C® Cervical Disc (Mobi-C), is the first cervical disc replacement FDA approved for both one and two-level indications. Designed to restore segmental motion and disc height, Mobi-C was approved after an extensive Investigational Device Exemption (IDE) study. In the two-level arm of the IDE, Mobi-C demonstrated superiority in overall trial success compared to fusion at 84 months. Zimmer Biomet Spine is committed to advancing cervical arthroplasty as the standard of care in indicated patients.

    TrellOss™ Porous Ti Interbody System

    TrellOss is a family of 3D printed titanium interbodies featuring a scaffold structure with 70 percent porosity and a seven micron roughened surface topography to foster a cellular relevant environment for adhesion and bone ingrowth1. The TrellOss platform includes TrellOss-C (cervical), TrellOss-C SA (Cervical stand-alone), TrellOss-TC (TLIF curved), TrellOss-TS (TLIF straight), TrellOss-L (Lateral) and TrellOss-A (ALIF).

    • Tether™

    Zimmer Biomet's anterior vertebral body tethering (AVBT) solution, The Tether, provides an alternative to fusion for young patients requiring surgery for scoliosis. The Tether uses a strong, flexible cord to pull on the outside of a scoliosis curve to initially straighten the spine, while the inside of the curve is left free to grow. Unlike fusion alternatives, The Tether is positioned utilizing an endoscopic minimally invasive approach through a few small openings between the ribs.

    About Zimmer Biomet

    Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. We design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; office based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.

    We collaborate with healthcare professionals around the globe to advance the pace of innovation. Our products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Together with healthcare professionals, we help millions of people live better lives.

    We have operations in more than 25 countries around the world and sell products in more than 100 countries. For more information, visit www.zimmerbiomet.com or follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet

    Apple Watch and iPhone are trademarks of Apple, Inc., registered in the U.S. and other countries.

    Patients must have a compatible smartphone and deemed by their surgeon as appropriate candidates for app-guided post-op rehabilitation.

    For product information, including indications, contraindications, warnings, precautions, potential adverse effects, and patient counseling information, see the package insert. For additional product information, see www.zimmerbiomet.com.


    1. McGilvray KC, Easley J, Seim HB, et al. Bony ingrowth potential of 3D-printed porous titanium alloy: a direct comparison of interbody cage materials in an in vivo ovine lumbar fusion model. Spine J 2018;18(7):1250-1260.

 Featured Products

  • Mobi-C Cervical Disc
    Statistical Superiority in Overall Trial Success Compared to Fusion for Two-Level Disc Replacement at Seven Years...

  • ​Mobi-C – Clinical Trial Results at 7-Years (IDE Data):

    In the one-level study, Mobi-C demonstrated non-inferiority to anterior cervical discectomy and fusion (ACDF) as reflected in the primary composite endpoint. In the two-level study Mobi-C demonstrated SUPERIORITY to ACDF in the primary composite endpoint. Key results from the two-level study include:

    • Overall trial success was 60.8% for Mobi-C and 34.6% for fusion, which represents statistical superiority (p=0.0002).
    • The rate of subsequent surgeries at the operated level for Mobi-C was 5.6% versus 17.1% for fusion.
    • The percentage of subjects who demonstrated clinically relevant adjacent segment degeneration (determined by x-ray) was:
      • 5.3% of Mobi-C patients compared to 40.0% of ACDF patients at the inferior adjacent level
      • 11.0% of Mobi-C patients compared to 26.7% of ACDF patients at the superior adjacent level
    • Mean return to work time was 20.9 days sooner for Mobi-C patients compared to fusion patients.
    • Mobi-C subjects on average required fewer subsequent surgeries at the operated level(s) compared to ACDF for both one and two levels.

    To review complete trial results from the Investigational Device Exemption (IDE) study visit https://www.cervicaldisc.com/complete-trial-results

    Additionally, because of the unique motion-restoring characteristics of the Mobi-C device, many misconceptions about mobility in certain portions of the patient population have been put-forth.  Zimmer Biomet has partnered with Dr. Michael S. Hisey of the Texas Back Institute to bring you “Does High Mobility Affect Patient Outcomes after Arthroplasty with the Mobi-C® Cervical Disc?”   Specific highlights from the paper:

    1.            High mobility did not correspond to poor outcomes in the Mobi-C IDE cohort.

    2.            There was no significant difference in NDI or neck pain between high and normal ROM.

    3.            There was no risk of adverse events associated with high mobility.

    Paper can be found here : http://www.cervicaldisc.com/highmobility

  • The Tether™ - Vertebral Body Tethering System
    The Tether™ is the first and only FDA-Approved Vertebral Body Tethering System and a potential alternative to spinal fusion for the treatment for idiopathic scoliosis in skeletally immature patients....

  • The Tether™ uses a strong, flexible cord to treat idiopathic scoliosis in skeletally immature patients.

    Clinical data suggests The Tether provides probable benefit in the treatment of idiopathic scoliosis. A single-center, non-randomized FDA Investigational Device Exemption (IDE) study with 57 patients demonstrated a reduction in the average main Cobb angle by 65% (from 40.4° to 14.3°) at 24-months post-op and a total success rate of 94.6% at the most recent visit (mean 49.8 months).

    The Tether is indicated for skeletally immature patients that require surgical treatment to obtain and maintain correction of progressive idiopathic scoliosis, with a major Cobb angle of 30 to 65 degrees, whose osseous structure is dimensionally adequate to accommodate screw fixation, as determined by radiographic imaging. Patients should have failed bracing and/or be intolerant to brace wear.

    Please visit www.myscoliosis.com for additional product information, IDE study results, risks, and contraindications.

  • mymobility ® with Apple Watch®
    mymobility ® with Apple Watch® is a digital care management system that uses iPhone® mobile device and Apple Watch ...

  • Transforming the Standard of Care through New Data

    With this exclusive partnership, we are bringing gait quality and intensity data metrics into the mymobility with Apple Watch platform.

    How it works:

    • Leverages the power of sensors in the Apple Watch and iPhone, to assess gait quality and intensity compared to step counts alone.
    • Patients will receive a daily walking goal to capture gait metrics for their surgeon’s review and walking speed milestones, so patients receive progress feedback between office visits regarding their functional recovery.
    • The metrics will be paired with alerts to help clinicians efficiently identify patients who based this gait assessment may not be on-track with their recovery.

    These new features are another step in transforming the standard of care in musculoskeletal health, enabling a more robust view of care informed by data captured throughout the patient’s episode of care.

    mymobility with Apple Watch is a digital care management system that uses iPhone® and Apple Watch to facilitate a first-of-its-kind level of connection between patients and their surgeons to improve the patient journey. It delivers continuous data and patient-reported feedback to surgeons in order to facilitate care, outcomes and satisfaction. mymobility with Apple Watch helps surgeons deliver support and guidance to their patients through a connected experience while the app collects and monitors objective data about their patients’ surgical preparation and recovery.

    Why mymobility?

    • Self-directed in-app video exercises allow reduced supervised physical therapy to qualified* patients.
    • Supports PROMs required quality metric tracking.
    • Messaging by text, video or picture is intended to support the patient experience and reduce costs of potential unnecessary visits.
    • Physiologic tracking provides the clinician with insights into their patients’ recovery.

    Available Care Plans for Spine: Cervical Disc Arthroplasty, Cervical Fusion, Cervical Non-fusion, Lumbar Fusion, Lumbar Non-fusion


    Patients must have an iPhone 6 or higher (excluding 2016 and 2017 iPhone SE) to use the mymobility app. Apple Watch and iPhone are trademarks of Apple Inc., registered it the U.S. and other countries. This material is intended for healthcare professionals. Patients must have their own compatible mobile device to use mymobility. Not all patients are candidates for unsupervised physical therapy and surgeons need to evaluate which patients are appropriate candidates for this pathway. © 2020 Zimmer Biomet

  • ROSA ONE® Spine
    ROSA ONE® Spine is a robotic and surgical navigation system designed to aid surgeons in performing minimally invasive thoracolumbar spine procedures. ROSA ONE Spine is designed to accommodate the surgical workflow....

  • ROSA ONE provides both Brain and Spine applications on one system. The dual function
    robot can increase the utilization of the robotic platform for surgeries – which can lead to
    decreased acquisition, service, repair, costs and can streamline the robotic learning curve
    across the institution. ROSA ONE Spine includes a robotic assistant and a suite of navigation technologies
    designed to improve implant as well as instrument placement accuracy and predictability.
    With six degrees of freedom, ROSA ONE Spine allows dexterity and flexibility to access
    surgical sites. Once the trajectory has been set, the rigidity of the robotic arm provides
    gesture stability. ROSA ONE Spine removes the need for a rigid connection to the patient or the table.
    This enables seamless surgical workflow integration and provides the surgeon with the
    flexibility of using robotics and navigation. Unique ‘dynamic tracking’ functionality allows the robot to move in real time, in sync
    with the patient’s movements.
  • TrellOss-C SA
    A 3D printed titanium cervical standalone device featuring a scaffold structure with 70% porosity and a 7 micron roughened surface topography to foster a cellular relevant environment for adhesion and bone ingrowth.1...

  • TrellOss-C SA Implant
    • Possesses combined functionality and benefits of a cervical interbody and an anterior cervical plate
    • Implant is contained within the region of the excised disc space and is designed to not protrude past
    the mid-line edge of the vertebral bodies, reducing the amount of soft tissue damage or irritation
    • Implants are sterile-packed for reduced risk of contamination and hospital reprocessing costs
    • Roughened surface provides initial stabilization and integrated turn lock allows for visual confirmation
    of locked position
    • System offers guided and self-guided straight, fixed-angle, and poly-axial instruments to accommodate
    surgeon preference

    1. McGilvray KC, Easley J, Seim HB, et al. Bony ingrowth potential of 3D-printed porous titanium alloy: a direct comparison of interbody cage materials in an in vivo ovine lumbar fusion model. Spine J 2018;18(7):1250-1260.


Send Email

Type your information and click "Send Email" to send an email to this exhibitor. To return to the previous screen without saving, click "Reset".